(Q35034105)

English

Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor (English)

1 reference

Europe PubMed Central

5 August 2017

author name string

Bernard R Chaitman

1

1 reference

Europe PubMed Central

5 August 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

5 August 2017

Current Problems in Cardiology

1 reference

Europe PubMed Central

5 August 2017

27

1 reference

Europe PubMed Central

5 August 2017

12

1 reference

Europe PubMed Central

5 August 2017

527-555

1 reference

Europe PubMed Central

5 August 2017

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on M

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Health status predicts long-term outcome in outpatients with coronary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Isosorbide-5-Mononitrate and Atenolol in the Treatment of Stable Exertional Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of felodipine versus nifedipine on exercise tolerance in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effort angina with adequate beta-receptor blockade: comparison with diltiazem alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Response of angina and ischemia to long-term treatment in patients with chronic stable angina: A double-blind randomised individualized dosing trial of nifedipine, propranolol and their combination

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Atenolol or nicardipine alone is as efficacious in stable angina as their combination: a double blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine versus nadolol in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The total ischemic burden European trial (TIBET): design, methodology, and management. The TIBET Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The combination of nifedipine and propranolol in the management of patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina of effort

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Variability of exercise performance during long-term placebo treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial exercise testing in patients with effort angina: variable tolerance, fixed threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission of clinical angina pectoris: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible?

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuation of myocardial ischemia with repeated exercise in subjects with chronic stable angina: relation to myocardial contractility, intensity of exercise and the adenosine triphosphate-sensitive potassium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved efficacy of high-dose versus medium- and low-dose diltiazem therapy for chronic stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Diltiazem and propranolol combination for the treatment of chronic stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of diltiazem and propranolol, alone and in combination, in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardio

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic modulation: a means to mend a broken heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of metabolically active drugs in the management of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ranolazine: a potential new treatment for chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ranolazine: a novel metabolic modulator for the treatment of angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chelation therapy for ischemic heart disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidural spinal electrical stimulation for severe angina: a study of its effects on symptoms, exercise tolerance and degree of ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Spinal cord stimulation for chronic intractable angina pectoris: a unified theory on its mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Refractory angina pectoris: mechanism and therapeutic options.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New approaches to the pharmacological treatment of angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ranolazine attenuates palmitoyl-L-carnitine-induced mechanical and metabolic derangement in the isolated, perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ranolazine on ischemic threshold, coronary sinus blood flow, and myocardial metabolism in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ranolazine (RS-43285): a preliminary study of a new anti-anginal agent with selective effect on ischaemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The characterization of the metabolites of ranolazine in man by liquid chromatography mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of ranolazine and eleven phase I metabolites in human plasma by liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry with selected-ion monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of a medical food for the dietary management of chronic, stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination treatment with trimetazidine and diltiazem in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2802%2970007-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0146-2806(02)70007-8

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35034105&oldid=2047506801"